Related references
Note: Only part of the references are listed.Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up
S. Jann et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
How to assess new drugs for neuropathies: advances in trial design and methodology
Pieter A. van Doorn et al.
CURRENT OPINION IN NEUROLOGY (2008)
Immunotherapy of chronic inflammatory demyelinating polyradiculoneuropathy
F. Eftimov et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
Richard A. C. Hughes et al.
LANCET NEUROLOGY (2008)
Evidence for long-term IVIg treatment of chronic inflammatory demyelinating polyradiculoneuropathy
Eduardo Nobile-Orazio
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Idiopathic chronic inflammatory demyelinating polyneuropathy:: an epidemiological study in Italy
A. Chio et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP
D Cocito et al.
JOURNAL OF NEUROLOGY (2002)
Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy
KR Sharma et al.
ARCHIVES OF NEUROLOGY (2002)
Share Paper
